2024 HCPCS Code C9767
Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed
TAGS: lower angioplasty stent performed intravascular within transluminal extremity lithotripsy
Short Description | Revasc lithotrip-stent-ather |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | July 01, 2020 |
HCPCS Code Added Date | July 01, 2020 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C8930 - Tte w or w/o contr, cont ecg
- C8931 - Mra, w/dye, spinal canal
- C8932 - Mra, w/o dye, spinal canal
- C8933 - Mra, w/o&w/dye, spinal canal
- C8934 - Mra, w/dye, upper extremity
- C8935 - Mra, w/o dye, upper extr
- C8936 - Mra, w/o&w/dye, upper extr
- C8937 - Cad breast mri
- C8957 - Prolonged iv inf, req pump
- C9014 - Injection, cerliponase alfa
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
- C9027 - Injection, pembrolizumab
- C9028 - Inj. inotuzumab ozogamicin